Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors

Area of Science:

• Biotechnology and Nanomedicine
• Oncology
• Bacteriology

Background:

• Outer membrane vesicles (OMVs) are bacterial nanoparticles with inherent properties suitable for therapeutic applications.
• Gastrointestinal (GI) tumors present significant challenges due to resistance to conventional therapies and limitations of current immunotherapies.
• OMVs offer a versatile platform for developing novel, individualized cancer treatments.

Purpose of the Study:

• To review recent advancements in engineering outer membrane vesicles (OMVs) for gastrointestinal tumor therapy.
• To discuss the potential of OMV-based strategies for overcoming treatment resistance and enhancing anti-tumor immunity.
• To highlight challenges and opportunities for the clinical translation of OMV-based therapies.

Main Methods:

• Literature review of OMV engineering techniques for therapeutic applications.
• Analysis of OMV properties relevant to cancer treatment, including immunogenicity, stability, and tumor targeting.
• Examination of OMV-based combination therapies and personalized treatment approaches for GI cancers.

Main Results:

• Engineered OMVs demonstrate improved production, reduced toxicity, and enhanced safety and efficacy.
• OMVs can be modified to optimize anti-tumor immune responses and enable combination therapies.
• OMV-based strategies show promise for personalized treatment of refractory GI tumors.

Conclusions:

• OMV engineering provides a flexible platform for developing advanced therapies against GI malignancies.
• Further research and development are crucial for overcoming challenges in the clinical translation of OMV-based cancer treatments.
• OMV-based approaches hold significant potential for improving outcomes in gastrointestinal oncology.